Open3.500 | Close3.470 |
Vol / Avg.35.656K / 351.189K | Mkt Cap47.315M |
Day Range3.341 - 3.600 | 52 Wk Range2.034 - 8.730 |
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
Open3.500 | Close3.470 |
Vol / Avg.35.656K / 351.189K | Mkt Cap47.315M |
Day Range3.341 - 3.600 | 52 Wk Range2.034 - 8.730 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.970 | -1.750 | 0.2200 | ||||
REV | 114.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.990 | -2.820 | -0.8300 | ||||
REV | 100.000K | 135.000K | 35.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-10-30 | HC Wainwright & Co. | Joseph Pantginis | Maintains | BuyBuy | Lowers | 28.00 | 5.75 |
2023-08-14 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | 28.00 | 28.00 |
2023-05-12 | Cantor Fitzgerald | Louise Chen | Maintains | Overweight | Raises | 5.00 | 9.00 |
2023-05-12 | HC Wainwright & Co. | Joseph Pantginis | Reiterates | BuyBuy | Maintains | - | 28.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VYNE | VYNE Therapeutics | 2.42% | 47.3M |
CPIX | Cumberland | 25% | 29.2M |
ITRM | Iterum Therapeutics | 13.3% | 27.8M |
SCYX | SCYNEXIS | 1.79% | 63.6M |
CALC | CalciMedica | -14.46% | 20.2M |
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Other companies in VYNE Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, October 30, 2023. The analyst firm set a price target for 5.75 expecting VYNE to rise to within 12 months (a possible 69.62% upside). 7 analyst firms have reported ratings in the last year.
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.39 last updated December 1, 2023 at 9:00 PM UTC.
There is no dividend information for VYNE Therapeutics.
VYNE Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for VYNE Therapeutics.
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.